Current drugs for antimalarial chemoprophylaxis: a review of efficacy and safety.
Jong
E C
EC
Department of Medicine, University of Washington, Seattle, Washington 98195, USA.
Nothdurft
H D
HD
D000962:Antimalarials / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D053626:Atovaquone; D002738:Chloroquine / Q000627:therapeutic use; D004318:Doxycycline / Q000627:therapeutic use; D006801:Humans; D008288:Malaria / Q000517:prevention & control*; D015767:Mefloquine / Q000627:therapeutic use; D009285:Naphthoquinones / Q000627:therapeutic use; D011319:Primaquine / Q000627:therapeutic use; D002727:Proguanil / Q000627:therapeutic use
D000962:Antimalarials; D009285:Naphthoquinones; D002738:Chloroquine; D011319:Primaquine; D004318:Doxycycline; D002727:Proguanil; D015767:Mefloquine; D053626:Atovaquone